Pentocur 1 g Pulver till injektionsvätska, lösning

País: Suècia

Idioma: suec

Font: Läkemedelsverket (Medical Products Agency)

ingredients actius:

tiopentalnatrium

Disponible des:

Abcur AB

Codi ATC:

N01AF03

Designació comuna internacional (DCI):

sodium thiopental

Dosis:

1 g

formulario farmacéutico:

Pulver till injektionsvätska, lösning

Composición:

tiopentalnatrium 1 g Aktiv substans

tipo de receta:

Receptbelagt

Resumen del producto:

Förpacknings: Injektionsflaska, 1 x 1 st (1 g); Injektionsflaska, 10 x 1 st (1 g); Injektionsflaska, 20 x 1 st (1 g); Injektionsflaska, 50 x 1 st (1 g)

Estat d'Autorització:

Godkänd

Data d'autorització:

2012-12-06

Fitxa tècnica

1
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Pentocur 0.5 g powder for solution for injection
Pentocur 1 g powder for solution for injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each vial of Pentocur 0.5 g powder for solution for injection contains
500 mg thiopental sodium (as
thiopental sodium and sodium carbonate).
Each vial of Pentocur 1 g powder for solution for injection contains
1000 mg thiopental sodium (as
thiopental sodium and sodium carbonate).
Excipients with known effect:
Each vial of Pentocur 0.5 g contains 2.2-2.4 mmol sodium (51-56 mg).
Each vial of Pentocur 1 g contains 4.4-4.9 mmol sodium (102-112 mg).
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Powder for solution for injection
Yellowish-white powder
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Intravenous anaesthesia.
Induction of general anaesthesia and also as an adjunct to provide
hypnosis during balanced anaesthesia with
other anaesthetic agents, including analgesics and muscle relaxants.
As an adjunct for control of
_ _
refractory convulsive disorders of various aetiology, including those
caused by
local anaesthetics.
Reducing the intracranial pressure in patients with increased
intracranial pressure, if controlled ventilation is
provided.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Using of thiopental is reserved only for health care personnel trained
in anaesthesiology. A person qualified
in the use of anaesthetics should be constantly available during the
administration of the medicinal product.
After continuous administration of thiopental the effect duration is
prolonged, personnel qualified in the use
of anaesthetics should be constantly available during the
administration of the medicinal product.
A normal adult dose for induction of anaesthesia is 4-6 mg/kg body
weight, but the individual response to the
drug is so varied that there can be no fixed dosage. The drug should
be titrated against patient requirements
as governed by age, sex, body weight and the p